Revance Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/12/2025

Shares

2,297,582

Value ($000)

6,986

Weight

0.0%

2014 Q1 - 2024 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/12/2025	6,986	0.0%	2,297,582	12/31/2024
2024 Q3	11/12/2024	11,885	0.0%	2,289,654	9/30/2024
2024 Q2	8/9/2024	5,907	0.0%	2,297,965	6/30/2024
2024 Q1	5/13/2024	9,698	0.0%	1,970,838	3/31/2024
2023 Q4	2/13/2024	16,918	0.0%	1,924,421	12/31/2023
2023 Q3	11/13/2023	20,422	0.0%	1,780,277	9/30/2023
2023 Q2	8/11/2023	42,913	0.0%	1,695,510	6/30/2023
2023 Q1	5/15/2023	51,424	0.0%	1,596,514	3/31/2023
2022 Q4	2/13/2023	28,325	0.0%	1,534,445	12/31/2022
2022 Q3	11/14/2022	37,347	0.0%	1,383,241	9/30/2022
2022 Q2	8/12/2022	17,094	0.0%	1,236,952	6/30/2022
2022 Q1	5/13/2022	26,055	0.0%	1,336,191	3/31/2022
2021 Q4	2/11/2022	21,413	0.0%	1,312,080	12/31/2021
2021 Q3	11/12/2021	33,554	0.0%	1,204,388	9/30/2021
2021 Q2	8/13/2021	35,680	0.0%	1,203,811	6/30/2021
2021 Q1	5/12/2021	31,318	0.0%	1,120,508	3/31/2021
2020 Q4	2/12/2021	28,115	0.0%	992,094	12/31/2020
2020 Q3	11/13/2020	23,648	0.0%	940,676	9/30/2020
2020 Q2	8/13/2020	19,473	0.0%	797,452	6/30/2020
2020 Q1	5/14/2020	10,713	0.0%	723,870	3/31/2020
2019 Q4	2/13/2020	9,529	0.0%	587,152	12/31/2019
2014 Q1	5/14/2014	1,106	0.0%	35,143	3/31/2014